Caissa Capital Management ltd. - May 24, 2023 Form 4 Insider Report for Avalo Therapeutics, Inc. (AVTX)

Role
10%+ Owner
Signature
Cambyz Golestaneh, Title: Director
Stock symbol
AVTX
Transactions as of
May 24, 2023
Transactions value $
$26,816
Form type
4
Date filed
5/24/2023, 04:15 PM
Previous filing
May 22, 2023
Next filing
May 30, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVTX Common Stock Purchase $10.5K +3.48K +0.25% $3.01* 1.38M May 24, 2023 See Footnote (1) F1, F2
transaction AVTX Common Stock Purchase $16.3K +5.52K +0.4% $2.96* 1.38M May 24, 2023 See Footnote (1) F1, F3
holding AVTX Common Stock 182K May 24, 2023 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares held by Caissa Capital Management Ltd, a British Virgin Islands company controlled by Mr. Golestaneh.
F2 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $3.0 to $3.01, inclusive.
F3 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.92 to $3.03, inclusive.
F4 These shares are directly owned by Mr. Golestaneh in his personal capacity.